Andrew Cheng insider trades: Akero Therapeutics (AKRO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Andrew reports to the SEC
Open-market buys and sales
47 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 10, 2025 | AKRO | ↓ Sell | 30,000 | $53.98 | $1.6M | Direct | Oct 14, 2025 (4d) |
| Sep 11, 2025 | AKRO | ↓ Sell | 31,796 | $43.23 | $1.4M | Direct | Sep 12, 2025 (1d) |
| Aug 11, 2025 | AKRO | ↓ Sell | 30,000 | $48.59 | $1.5M | Direct | Aug 13, 2025 (2d) |
| Jul 10, 2025 | AKRO | ↓ Sell | 30,000 | $51.16 | $1.5M | Direct | Jul 11, 2025 (1d) |
| Jun 18, 2025 | AKRO | ↓ Sell | 6,620 | $54.84 | $363K | Direct | Jun 20, 2025 (2d) |
| Jun 10, 2025 | AKRO | ↓ Sell | 37,837 | $54.05 | $2.0M | Direct | Jun 12, 2025 (2d) |
| May 12, 2025 | AKRO | ↓ Sell | 30,000 | $41.48 | $1.2M | Direct | May 13, 2025 (1d) |
| Apr 10, 2025 | AKRO | ↓ Sell | 30,000 | $35.23 | $1.1M | Direct | Apr 11, 2025 (1d) |
| Mar 12, 2025 | AKRO | ↓ Sell | 1,738 | $44.88 | $78K | Direct | Mar 14, 2025 (2d) |
| Mar 10, 2025 | AKRO | ↓ Sell | 30,000 | $41.77 | $1.3M | Direct | Mar 12, 2025 (2d) |
| Feb 10, 2025 | AKRO | ↓ Sell | 30,000 | $52.73 | $1.6M | Direct | Feb 11, 2025 (1d) |
| Jan 27, 2025 | AKRO | ↓ Sell | 30,000 | $54.90 | $1.6M | Direct | Jan 29, 2025 (2d) |
| Dec 10, 2024 | AKRO | ↓ Sell | 7,855 | $30.79 | $242K | Direct | Dec 12, 2024 (2d) |
| Dec 2, 2024 | AKRO | ↓ Sell | 25,000 | $32.09 | $802K | Direct | Dec 4, 2024 (2d) |
| Nov 1, 2024 | AKRO | ↓ Sell | 108,366 | $31.73 | $3.4M | Direct | Nov 5, 2024 (4d) |
| Oct 18, 2024 | AKRO | ↓ Sell | 91,634 | $31.41 | $2.9M | Direct | Oct 18, 2024 (0d) |
| Sep 10, 2024 | AKRO | ↓ Sell | 1,738 | $26.18 | $46K | Direct | Sep 13, 2024 (3d) |
| Jun 11, 2024 | AKRO | ↓ Sell | 7,894 | $22.64 | $179K | Direct | Jun 13, 2024 (2d) |
| Mar 13, 2024 | AKRO | ↓ Sell | 1,969 | $28.33 | $56K | Direct | Mar 15, 2024 (2d) |
| Mar 4, 2024 | AKRO | ↓ Sell | 75,000 | $32.87 | $2.5M | Direct | Mar 6, 2024 (2d) |
| Dec 14, 2023 | AKRO | ↓ Sell | 1,628 | $20.76 | $34K | Direct | Dec 18, 2023 (4d) |
| Dec 11, 2023 | AKRO | ↓ Sell | 26,978 | $20.02 | $540K | Direct | Dec 11, 2023 (0d) |
| Oct 2, 2023 | AKRO | ↓ Sell | 25,000 | $47.91 | $1.2M | Direct | Oct 4, 2023 (2d) |
| Sep 13, 2023 | AKRO | ↓ Sell | 1,682 | $50.34 | $85K | Direct | Sep 25, 2023 (12d) |
| Sep 1, 2023 | AKRO | ↓ Sell | 25,000 | $49.77 | $1.2M | Direct | Sep 18, 2023 (17d) |
| Aug 1, 2023 | AKRO | ↓ Sell | 25,000 | $43.15 | $1.1M | Direct | Aug 3, 2023 (2d) |
| Jul 3, 2023 | AKRO | ↓ Sell | 25,000 | $44.88 | $1.1M | Direct | Jul 6, 2023 (3d) |
| Jun 13, 2023 | AKRO | ↓ Sell | 1,613 | $55.16 | $89K | Direct | Jun 15, 2023 (2d) |
| Jun 1, 2023 | AKRO | ↓ Sell | 25,000 | $45.10 | $1.1M | Direct | Jun 5, 2023 (4d) |
| May 1, 2023 | AKRO | ↓ Sell | 25,000 | $45.07 | $1.1M | Direct | May 3, 2023 (2d) |
| Apr 3, 2023 | AKRO | ↓ Sell | 25,000 | $37.94 | $949K | Direct | Apr 5, 2023 (2d) |
| Mar 1, 2023 | AKRO | ↓ Sell | 25,000 | $46.65 | $1.2M | Direct | Mar 3, 2023 (2d) |
| Feb 1, 2023 | AKRO | ↓ Sell | 25,000 | $49.06 | $1.2M | Direct | Feb 3, 2023 (2d) |
| Jan 3, 2023 | AKRO | ↓ Sell | 25,000 | $51.27 | $1.3M | Direct | Jan 5, 2023 (2d) |
| Dec 1, 2022 | AKRO | ↓ Sell | 10,000 | $46.07 | $461K | Direct | Dec 2, 2022 (1d) |
| Nov 1, 2022 | AKRO | ↓ Sell | 10,000 | $43.42 | $434K | Direct | Nov 2, 2022 (1d) |
| Oct 3, 2022 | AKRO | ↓ Sell | 10,000 | $33.23 | $332K | Direct | Oct 5, 2022 (2d) |
| Sep 13, 2022 | AKRO | ↓ Sell | 60,000 | $27.42 | $1.6M | Direct | Sep 15, 2022 (2d) |
| Mar 1, 2022 | AKRO | ↓ Sell | 10,000 | $17.59 | $176K | Direct | Mar 2, 2022 (1d) |
| Feb 1, 2022 | AKRO | ↓ Sell | 10,000 | $17.56 | $176K | Direct | Feb 3, 2022 (2d) |
| Dec 2, 2021 | AKRO | ↓ Sell | 17,500 | $20.18 | $353K | Direct | Dec 3, 2021 (1d) |
| Nov 2, 2021 | AKRO | ↓ Sell | 17,500 | $22.57 | $395K | Direct | Nov 3, 2021 (1d) |
| Oct 4, 2021 | AKRO | ↓ Sell | 17,500 | $21.54 | $377K | Direct | Oct 5, 2021 (1d) |
| Sep 2, 2021 | AKRO | ↓ Sell | 17,500 | $23.89 | $418K | Direct | Sep 3, 2021 (1d) |
| Aug 3, 2021 | AKRO | ↓ Sell | 17,500 | $20.83 | $365K | Direct | Aug 4, 2021 (1d) |
| Jul 2, 2021 | AKRO | ↓ Sell | 17,500 | $24.78 | $434K | Direct | Jul 6, 2021 (4d) |
| Jan 10, 2021 | AKRO | ↓ Sell | 10,000 | $19.55 | $196K | Direct | Jan 11, 2022 (366d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Andrew Cheng's insider trades
Andrew Cheng is President and CEO at Akero Therapeutics (AKRO). Since Jan 10, 2021, Andrew has reported no open-market purchases and 47 sales worth $43.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (35 filings), grants and awards (21 filings), gifts (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AKRO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.